Description: Panelists discuss: [1] Practice Bulletin 8 that was written for FAS 97, [2] Purchase GAAP [PGAAP], and [3] GAAP for re-entry term products. Session 10 of the 1991 Valuation Actuary Symposium.

Description: This session at the 1998 Valuation Actuary Symposium looks at FAS 133, GAAP accounting for derivatives, including the impact on financial statements, implementation issues, and implications for the valuation actuary.

Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: This presentation is a Teaching Session, number 39TS, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The instructors discuss identification and measurement of intangible assets including value of in-force policies, or value of business acquired [VOBA], and goodwill impairment testing. Historical perspective is provided, including the original purchase GAAP [PGAAP] guidance, the diversity in practice among companies, and controversy and disagreements between auditors and actuaries. This continues with the efforts of the Emerging Issues Task Force [EITF] 92-9, the Securities and Exchange Commission [SEC] and its views on pooling, the Financial Accounting Standards Board [FASB] business combinations project, and the recent issuance by the FASB of FAS 141 and 142. The presentation includes experience from a real world application. Discussion from participants is included.

Description: This section presents book reviews and summaries of recent publications. Reviews: '1975 Annual Reports of the Board of Trustees of the Federal OASDI Trust Funds...' by the US Congress, 'Providing Adequate Retirement Income' by Schulz, Carrin, Krupp, Peschke, Sclar and Steenberge, 'Ernst & Ernst GAAP - Stock Life Companies' by Posnak, 'Reports of the Quadrennial Advisory Council on Social Security' by US Government, 'Fundamentals of Private Pensions' by McGill. Digests also included.

Description: This article describes that some companies are ‘approaching the problem of how to accommodate Universal Life in GAAP statements by using a simple method which produces not unreasonable results and waiting for consensus on appropriate methodology to develop. This describes so of the methodology currently in use.

Description: Life insurance companies find themselves in a significantly more complicated environment than that of just a few years ago. Managements face an uncertain investment environment, the real possibility of deteriorating future mortality due to the spread of AIDS, and alternative and competing distribution systems.

Description: A reflection on the need/desire for one right answer when there isn't one

Description: Performance measurement is not the primary purpose of either GAAP or statutory accounting. This article discusses alternative methods of reporting used by life insurance companies to better measure financial performance.

Description: US GAAP for Life Insurers chapter 4 spreadsheet. This spreadsheet shows the development of GAAP Profit/Loss statements along with benefit reserves and DAC and assumptions for several life insurance products such as 10 year endowment and 20 year term. Please see the book US GAAP for Life Insurers for full detail on US GAAP accounting.